Production of macrophage inflammatory protein-1α by human mast cells: Increased anti-IgE-dependent secretion after IgE-dependent enhancement of mast cell IgE-binding ability

Laboratory Investigation

Volumn 77, Issue 2, 1997, Pages 185-193

  Yano, Koji ^a   Yamaguchi, Masao ^a   De Mora, Fernando ^a   Lantz, Chris S ^a   Butterfield, Joseph H ^b   Costa, John J ^a   Galli, Stephen J ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIMYCIN; FC RECEPTOR; HISTAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; MACROPHAGE INFLAMMATORY PROTEIN 1; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE;

ALLERGY; ARTICLE; CONTROLLED STUDY; HISTAMINE RELEASE; HUMAN; HUMAN CELL; INFLAMMATION; LEUKEMIA CELL; MACROPHAGE FUNCTION; MAST CELL; PRIORITY JOURNAL;

ANTIBODIES, ANTI-IDIOTYPIC; HISTAMINE RELEASE; HUMANS; IMMUNOGLOBULIN E; MACROPHAGE INFLAMMATORY PROTEIN-1; MAST CELLS;

EID: 0030841669     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Alam R, Forsythe PA, Stafford S, Lett-Brown MA, and Grant A (1992). Macrophage inflammatory protein-1α activates basophils and mast cells. J Exp Med 176:781-786.
2. Alam R, York J, Boyars M, Stafford S, Grant JA, Lee J, Forsythe P, Sim T, and Ida N (1996). Increased MCP-1, RANTES, and MIP-1α in bronchoalveolar lavage fluid of allergic asthmatic patients. Am J Respir Crit Care Med 153:1398-1404.
3. Bates P (1996). Chemokine receptors and HIV-1: An attractive pair? Cell 86:1-3.
4. Beaven MA and Metzger H (1993). Signal transduction by Fc receptors: The FcεRI case. Immunol Today 14:222-226.
5. Bochner BS and Lichtenstein LM (1991). Anaphylaxis. N Engl J Med 324:1785-1790.
6. Burd PR, Rogers HW, Gordon JR, Martin CA, Jayaraman S, Wilson SD, Dvorak AM, Galli SJ, and Dorf ME (1989). Interleukin-3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med 170:245-257.
7. Butterfield JH, Weiler D, Dewald G, and Gleich GJ (1988). Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 12:345-355.
8. Conroy MC, Adkinson NF Jr, and Lichtenstein LM (1977). Measurements of IgE on human basophils: Relation to serum IgE and anti-IgE-induced histamine release. J Immunol 118: 1317-1321.
9. Cook DN, Beck MA, Coffman TM, Kirby SL, Sheridan JF, Pragnell IB, and Smithies O (1995). Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 269:1583-1585.
10. Costa JJ, Demetri GD, Harrist TJ, Dvorak AM, Hayes DF, Merica EA, Menchaca DM, Gringeri AJ, Schwartz LB, and Galli SJ (1996). Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med 183:2681-2686.
11. Costa JJ, Matossian K, Resnick MB, Beil WJ, Wong DTW, Gordon JR, Dvorak AM, Weller PF, and Galli SJ (1993). Human eosinophils can express the cytokines tumor necrosis factor-α and macrophage inflammatory protein-1α. J Clin Invest 91:2673-2684.
12. Dombrowicz D, Flamand V, Brigman KK, Koller BH, and Kinet J-P (1993). Abolition of anaphylaxis by targeted disruption of the high-affinity immunoglobulin E receptor α chain gene. Cell 75:969-975.
13. Ebisawa M, Shichijo M, Miura K, Tachimoto H, Katsunuma T, Onda T, Iikura Y, and Saito H (1995). Human mast cells produce TNF-α, MIP-1α and IL-5 following activation through FcεRI (abstract). J Allergy Clin Immunol 95:219.
14. Echtenacher B, Männel DN, and Hültner L (1996). Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381:75-77.
15. Fahey TJ III, Tracey KJ, Tekamp-Olson P, Cousens LS, Jones WG, Shires GT, Cerami A, and Sherry B (1992). Macrophage inflammatory protein 1 modulates macrophage function. J Immunol 148:2764-2769.
16. Furitsu T, Tsujimura T, Tono T, Ikeda H, Kitayama H, Koshimizu U, Sugahara H, Butterfield JH, Ashman LK, Kanayama Y, Matsuzawa Y, Kitamura Y, and Kanakura Y (1993). Identification of mutations in the coding region of the protooncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 92:1736-1744.
17. Galli SJ (1993). New concepts about the mast cell. N Engl J Med 328:257-265.
18. Galli SJ (1997). The mast cell: A versatile effector cell for a challenging world (Paul Kallós Memorial Lecture). Int Arch Allergy Immunol 113:14-22.
19. Galli SJ and Wershil BK (1996). The two faces of the mast cell (News and Views). Nature 381:21-22.
20. Galli SJ, Wershil BK, Gordon JR, and Martin TR (1989). Mast cells: Immunologically specific effectors and potential sources of multiple cytokines during IgE-dependent responses. In: Chadwick D, Evered D, and Whelan J, editors. IgE, mast cells and the allergic response (Ciba Foundation Symposium No. 147). Chichester, United Kingdom: John Wiley and Sons, 53-73.
21. Gounni AS, Lamkhioued B, Ochiai K, Tanaka Y, Delaporte E, Capron A, Kinet J-P, and Capron M (1994). High-affinity IgE receptor on eosinophils is involved in defense against parasites. Nature 367:183-186.
22. Hsu C and MacGlashan D Jr (1996). IgE antibody upregulates high-affinity IgE binding on murine bone marrow derived mast cells. Immunol Lett 52:129-134.
23. Ishizaka T and Ishizaka K (1984). Activation of mast cells for mediator release through IgE receptors. Prog Allergy 34:188-235.
24. Kimata H, Yoshida A, Ishioka C, Fujimoto M, Lindley I, and Furusho K (1996). RANTES and macrophage inflammatory protein 1α selectively enhance immunoglobulin (IgE) and lgG4 production by human B cells. J Exp Med 183:2397-2402.
25. Kimura I, Moritani Y, and Tanizaki Y (1973). Basophils in bronchial asthma with reference to reagin-type allergy. Clin Allergy 3:195-202.
26. Kita H and Gleich GJ (1996). Chemokines active on eosinophils: Potential roles in allergic inflammation. J Exp Med 183:2421-2426.
27. Lantz CS, Yamaguchi M, Oettgen HC, Katona IM, Miyajima I, Kinet J-P, and Galli SJ (1997). IgE regulates mouse basophil FcεRI expression in vivo. J Immunol 158:2517-2521.
28. Lloyd AR, Oppenheim JJ, Kelvin DJ, and Taub DD (1996). Chemokines regulate T cell adherence to recombinant adhesion molecules and extracellular matrix proteins. J Immunol 156:932-938.
29. Lukacs NW, Strieter RM, Warmington K, Lincoln P, Chensue SW, and Kunkel SL (1997). Differential recruitment of leukocyte populations and alteration of airway hyperreactivity by C-C family chemokines in allergic airway inflammation. J Immunol 158:4398-4404.
30. MacGlashan DW Jr, Bochner BS, Adelman DC, Jardieu PM, Togias A, McKenzie-White J, Sterbinsky SA, Hamilton RG, and Lichtenstein LM (1997). Down-regulation of FcεRI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol 158:1438-1445.
31. Malaviya R, Ikeda T, Ross E, and Abraham SN (1996). Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 381:77-80.
32. Maurer D, Fiebiger E, Reininger B, Wolff-Winiski B, Jouvin M-H, Kilgus O, Kinet J-P, and Stingl G (1994). Expression of functional high-affinity immunoglobulin E receptors (FcεRI) on monocytes of atopic individuals. J Exp Med 179:745-750.
33. Ownby DR (1993). Clinical significance of IgE. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, and Busse WW, editors. Allergy: Principles and practice, 4th ed. St. Louis: Mosby, 1059-1076.
34. Paul WE, Seder RA, and Plaut M (1993). Lymphokine and cytokine production by FcεRI+ cells. Adv Immunol 53:1-29.
35. Ravetch JV and Kinet J-P (1991). Fc receptors. Annu Revu Immunol 9:457-492.
36. Rodewald H-R, Dessing M, Dvorak AM, and Galli SJ (1996). Identification of a committed precursor for the mast cell lineage. Science 271:818-822.
37. Rot A, Krieger M, Brunner T, Bischoff SC, Schall TJ, and Dahinden CA (1992). RANTES and macrophage inflammatory protein-1α induce the migration and activation of normal human eosinophil granulocytes. J Exp Med 176:1489-1495.
38. 2 from cord blood mononuclear cells. J Immunol 157:343-350.
39. Saxon A, Diaz-Sanchez D, and Zhang K (1996). The allergic response in host defense. In: Rich RR, Fleisher TA, Schwartz BD, Shearer WT, and Strober W, editors. Clinical immunology: Principles and practice, vol 1. St. Louis: Mosby Year Book, 847-862.
40. Schwartz L and Huff T (1993). Biology of mast cells and basophils. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, and Busse WW, editors. Allergy: Principles and practice, 4th ed. St. Louis: Mosby, 135-168.
41. Selvan RS, Butterfield JH, and Krangel MS (1994). Expression of multiple chemokine genes by a human mast cell leukemia. J Biol Chem 269:13893-13898.
42. Stallman PJ, Aalberse RC, Bruhl PC, and Van Elven EH (1977). Experiments on the passive sensitization of human basophils, using quantitative immunofluorescence microscopy. Int Arch Allergy Appl Immunol 54:364-373.
43. Takai T, Li M, Sylvestre D, Clynes R, and Ravetch JV (1994). FcR γ chain deletion results in pleiotropic effector cell defects. Cell 76:519-529.
44. + T cells in response to MIP-1α and MIP-1β. Science 260:355-358.
45. Tsai M, Miyamoto M, Tam S-Y, Wang Z-s, and Galli SJ (1995). Detection of mouse mast cell-associated protease mRNA: Heparinase treatment greatly improves RT-PCR of tissues containing mast cell heparin. Am J Pathol 146:335-343.
46. Wang JM, Sherry B, Fivash MJ, Kelvin DJ, and Oppenheim JJ (1993). Human recombinant macrophage inflammatory protein-1α and -β and monocyte chemotactic and activating factor utilize common and unique receptors on human monocytes. J Immunol 150:3022-3029.
47. Wollenberg A, Kraft S, Hanau D, and Bieber T (1996). Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J Invest Dermatol 106:446-453.
48. Wolpe SD, Davatelis G, Sherry B, Beutler B, Hesse DG, Nguyen HT, Moldawer LL, Nathan CF, Lowry F, and Cerami A (1988). Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J Exp Med 167:570-581.
49. Wolpe SD and Cerami A (1989). Macrophage inflammatory proteins 1 and 2: Members of a novel superfamily of cytokines. FASEB J 3:2565-2573.
50. Yamaguchi M, Lantz CS, Oettgen HC, Katona IM, Fleming T, Miyajima I, Kinet J-P, and Galli SJ (1997a). IgE enhances mouse mast cell FcεRI expression in vitro and in vivo: Evidence for a novel amplification mechanism in IgE-dependent reactions. J Exp Med 185:663-672.
51. Yamaguchi M, Lantz CS, Oettgen HC, Katona IM, Fleming T, Yano K, Miyajima I, Kinet J-P, and Galli SJ (1997b). IgE enhances mouse and human mast cell FcεRI expression, which in turn enhances IgE-dependent mast cell mediator release (abstract). J Allergy Clin Immunol 99:S104.
52. Zipfel PF, Balke J, Irving SG, Kelly K, and Siebenlist U (1989). Mitogenic activation of human T cells induces two closely related genes which share structural similarities with a new family of secreted factors. J Immunol 142:1582-1590.